✦ LIBER ✦

Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry : Correlation with morphology

✍ Scribed by Peter R. Duggan; David Easton; Joanne Luider; Iwona A. Auer

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 127 KB
Volume: 88
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(20000215)88:4<894::aid-cncr21>3.0.co;2-o

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND. Immunophenotypic analysis is an established tool in the diagnosis

and classification of many hematolymphoid disorders; however, the role of flow cytometry (FC) in detecting bone marrow involvement during the staging of non-Hodgkin lymphoma (NHL) has yet to be defined.

📜 SIMILAR VOLUMES

Bone marrow staging of patients with non

Bone marrow staging of patients with non-Hodgkin's lymphoma : Is flow cytometry a useful test?

✍ Iwona Auer; Joanne Luider 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

Is Flow Cytometry a Useful Test? R epresenting a busy flow cytometry laboratory with an annual workload of approximately 1400 acute leukemia and malignant lymphoma cases, we read the article by Naughton et al. 1 with considerable interest. The authors concluded that "flow cytometry of bone marrow as

Bone marrow staging in patients with non

Bone marrow staging in patients with non-hodgkin's lymphoma : Is flow cytometry a useful test?

✍ Michael J. Naughton; Jay L. Hess; Mary M. Zutter; Nancy L. Bartlett 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

BACKGROUND. Flow cytometric analysis of bone marrow often is used as an adjunct

DNA flow cytometry of non-Hodgkin's lymp

DNA flow cytometry of non-Hodgkin's lymphomas: Correlation with cytologic grade and clinical relapse

✍ Uma Nahar Saikia; Pranab Dey; Harpreet Vohra; Subash Kumari Gupta 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

In this prospective study, we correlated cytological grading and clinical follow-up of non-Hodgkin's lymphomas (NHL) with DNA flow cytometry (FCM) data from fine-needle aspiration biopsy (FNAB) material. FNAB was performed from 34 successive cases of NHL, and the aspirated material was analyzed by D

LSA2–L2 protocol treatment of stage IV n

LSA2–L2 protocol treatment of stage IV non-hodgkin's lymphoma in children with partial and extensive bone marrow involvement

✍ Luz Duque-Hammershaimb; Norma Wollner; Denis R. Miller 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 2 views

Serum CA 125 is of clinical value in the

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma : Correlation with tumor parameters and disease activity

✍ Ikram A. Burney; Tariq Siddiqui; Imran Siddiqui 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni

Serum CA 125 is of clinical value in the

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma : Correlation with tumor parameters and disease activity

✍ Mario Lazzarino; Ester Orlandi; Catherine Klersy; Cesare Astori; Ercole Brusamol 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Background: Ca 125 is a glycoprotein produced by epithelial ovarian tumors and by mesothelial cells; its levels also have been shown to be elevated in patients with non-hodgkin's lymphoma (nhl). ## Methods: The authors evaluated serum ca 125 levels in patients with nhl to elucidate the frequen